BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals

admin_news admin_news
Jun 14, 2025 - 01:30
0 0
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
Read More